BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches

(OTC: BDPT) BioAdaptives, Inc. announces the successful completion of its commercial manufacturing and logistics supply chain readiness. The company will roll out its next-generation wellness platforms beginning next month. Over the past quarter, BioAdaptives has focused on securing high-quality, standardized raw materials and establishing partnerships with GMP-compliant manufacturing facilities. The company can meet anticipated market demand for its MyndSystem™ cognitive performance platform and its upcoming Xcellara™ cellular wellness products. The formulation of Xcellara™ is backed by human, double-blind, placebo-controlled clinical data showing a significant increase in circulating stem and progenitor cells. BioAdaptives plans to release detailed product specifications, launch timelines, and scientific dossiers in the coming weeks. The company’s formulations are grounded in published and clinical research involving nutrition, stem cell biology, adaptogens, cellular transport mechanisms, and cellular health.

BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night

BioAdaptives, Inc. (OTC: BDPT) announced the official launch of MyndSystem™ and its website. MyndSystem™ is a brain support system originally developed for professional fighters, now marketed to executives and aging adults as well. The system includes MyndMed™ for daytime performance and MyndRenew™ for nighttime repair, aiming to address brain challenges such as inflammation and oxidative stress. The company believes this platform could become an inspiring driver of growth. BioAdaptives will use X to share product updates and company news.